儿童甲状腺腺叶切除术后早期甲状腺功能减退的临床病程
该研究回顾性分析了2008至2020年费城儿童医院110例甲状腺腺叶切除术患儿的临床和生化资料,约28.2%发生术后甲减(24.5%亚临床甲减,3.6%明显甲减),12.7%启动左甲状腺素治疗,81.6%在术后12个月内恢复甲状腺功能正常;
要点
- 儿童腺叶切除术后约28.2%发生甲减,以亚临床甲减为主(24.5%)。
- 术前TSH升高与术后甲减风险增加相关(OR=1.8)。
- 自主功能性结节相关的术前TSH抑制是术后甲减的独立危险因素。
核心结论
- 儿童甲状腺腺叶切除术后应评估甲状腺功能以决定是否需要左甲状腺素治疗。
- 若TSH持续升高,尤其呈上升趋势或>10.0 mIU/L,应考虑左甲状腺素治疗。
- 自主功能性结节相关的术前TSH抑制是术后甲减的独立危险因素。
研究设计与样本
- 回顾性研究,纳入2008至2020年费城儿童医院接受甲状腺腺叶切除术的110例患儿。
- 回顾术前和术后的临床及生化表现。
主要发现
- 28.2%(31/110)发生术后甲减,其中亚临床甲减(TSH>4.5且<10.0 mIU/L)占24.5%(27/110),明显甲减(TSH>10.0 mIU/L)占3.6%(4/110)。
- 12.7%(14/110)启动左甲状腺素治疗。
- 81.6%(84/103)在术后12个月内恢复甲状腺功能正常。
- 排除自主功能性结节患者后,甲状腺功能正常组术前TSH中位数1.09(IQR 0.70-1.77)mIU/L,甲减组1.80(IQR 1.02-2.68)mIU/L。
关键数值与推荐
- 术后甲减定义为TSH升高,亚临床甲减为TSH>4.5且<10.0 mIU/L,明显甲减为TSH>10.0 mIU/L。
- 若TSH持续升高,尤其呈上升趋势或>10.0 mIU/L,应考虑左甲状腺素治疗。
临床怎么用
- 儿童腺叶切除术后应监测甲状腺功能,尤其关注TSH变化。
- 对术前TSH升高或存在自主功能性结节的患者,应加强术后甲减的筛查和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction: Thyroid lobectomy reduces risks of surgical complications and need for levothyroxine (LT4). We aimed at identifying the clinical course and risk factors for postlobectomy hypothyroidism to optimize surgical counseling and management in pediatric patients undergoing lobectomy. Methods: Clinical and biochemical presentations pre- and postlobectomy were retrospectively reviewed for 110 patients who underwent thyroid lobectomy between 2008 and 2020 at the Children's Hospital of Philadelphia. Results: Approximately 28.2% of patients (31/110) developed postlobectomy hypothyroidism defined by an elevated thyrotropin (TSH) level, including 24.5% (27/110) with subclinical hypothyroidism (TSH >4.5 and <10.0 mIU/L) and 3.6% (4/110) with overt hypothyroidism (TSH >10.0 mIU/L). LT4 was initiated in 12.7% (14/110) of cases. Most patients (81.6%; 84/103) recovered euthyroidism within 12 months postlobectomy. When excluding patients with autonomous nodule(s), median preoperative TSH was 1.09 (interquartile range [IQR] = 0.70-1.77) mIU/L and 1.80 (IQR = 1.02-2.68) mIU/L in euthyroid and hypothyroid patients, respectively, with multivariate logistic regression confirming the association between an increased preoperative TSH and postlobectomy hypothyroidism (odds ratio = 1.8 [confidence interval 1.08-3.13], p = 0.024). Of the patients who underwent thyroid lobectomy and developed postoperative hypothyroidism (n = 31), 38.7% (12/31) had a preoperative diagnosis of an autonomously functioning thyroid nodule. Conclusions: Thyroid function should be evaluated postlobectomy to assess the need for LT4. LT4 should be considered if the TSH remains elevated, especially if an upward trend is observed or TSH is >10.0 mIU/L. Suppressed preoperative TSH associated with autonomous nodules is an independent risk factor for postlobectomy hypothyroidism.
引用
- Baran JA, Bauer AJ, Halada S, et al. Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics. Thyroid. 2021. PMID: 34714171. doi:10.1089/thy.2021.0396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。